Published on 16/03/2015 by admin
Filed under Dermatology
Last modified 16/03/2015
This article have been viewed 2519 times
Murtaza Khan and John Berth-Jones
Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports
Grover disease is an acquired pruritic, papulovesicular eruption characterized histologically by focal acantholytic dyskeratosis. It is predominantly self-limiting. It is more common in middle-aged and elderly people, especially men, and involves mainly the trunk. The evolution is acute or chronic. The etiology is unknown, but excessive UV exposure, heat, sweating, and ionizing radiation are linked to the disease. Drugs, chemotherapeutic agents and cancers are also known triggers. Other skin disorders such as psoriasis or eczema of various types may coexist.
Grover disease is an uncommon disorder characterized by discrete erythematous, edematous papulovesicles or keratotic papules. The duration of the eruption may be weeks to months and it may be persistent or recurrent. Pruritus of variable intensity is experienced by most patients and may be out of proportion to the clinical signs. Constitutional symptoms are usually absent.
Treatment is difficult. There have been no large clinical trials and reports are based on small numbers.
Patients should be advised to avoid excessive sun exposure, strenuous exercise, heat, and occlusive fabrics. In mild cases, simple antipruritic measures such as avoidance of soap, simple emollients, and soothing baths with bath oils or colloidal oatmeal may be of benefit. Wet compresses with zinc oxide, calamine, or topical corticosteroids may help to relieve the itching.
Topical calcipotriol (ointment) twice daily 50 µg/g may be helpful after 3 to 4 weeks of treatment. Topical vitamin A acid (retinoic acid) is of limited use owing to skin irritation.
Systemic therapy may be indicated in more extensive and persistent disease. Oral vitamin A has been recommended in the past. The aromatic retinoid acitretin been used successfully in doses of 0.5 mg/kg daily. Isotretinoin 40 mg daily has been used for periods ranging from 2 to 12 weeks. It may be administered on a reducing regimen if the initial response is rapid, with a maintenance dose of 10 mg daily. Side effects include dry skin, cheilitis, teratogenicity, and elevation of cholesterol and triglycerides.
Systemic corticosteroids have been used to suppress inflammation and pruritus, but relapses frequently occur on drug withdrawal.
Psoralen with UVA (PUVA) may be useful, but an initial exacerbation may occur. There are anecdotal reports of the success of narrowband UVB and of medium-dose UVA1 phototherapy.
Topical 5-fluorouracil, dapsone, antibiotics, and cryotherapy are ineffective. Recently rituximab and etanercept have been reported to be useful.
Skin biopsy
Acantholysis is the characteristic epidermal change. The histologic changes may mimic Darier disease, pemphigus, and Hailey–Hailey disease. Hyperkeratosis, parakeratosis, and spongiosis are other common epidermal changes. Immunofluorescence does not aid in making the diagnosis.
Heenan PJ, Quirk CJ. Br J Dermatol 1980; 102: 515–20.
This study looked at a series of 24 cases of transient acantholytic dermatosis. Most of them required topical fluorinated corticosteroids to control the pruritus, and two required intermittent courses of oral corticosteroids. Antihistamines were of limited value in controlling the pruritus.
French LE, Piletta PA, Etienne A, Salomon D, Saurat JH. Dermatology 1999; 198: 410–1.
Treatment of Skin Disease Comprehensive Therapeutic Strategies 4e
Emollients
Avoid heat/sweating
Topical corticosteroids
Antihistamines
